249 related articles for article (PubMed ID: 33842373)
1. mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications.
Lawal B; Lee CY; Mokgautsi N; Sumitra MR; Khedkar H; Wu ATH; Huang HS
Front Oncol; 2021; 11():656738. PubMed ID: 33842373
[TBL] [Abstract][Full Text] [Related]
2. A preclinical report of a cobimetinib-inspired novel anticancer small-molecule scaffold of isoflavones, NSC777213, for targeting PI3K/AKT/mTOR/MEK in multiple cancers.
Lawal B; Lo WC; Mokgautsi N; Sumitra MR; Khedkar H; Wu AT; Huang HS
Am J Cancer Res; 2021; 11(6):2590-2617. PubMed ID: 34249417
[TBL] [Abstract][Full Text] [Related]
3. Chemical Modification of Curcumin into Its Semi-Synthetic Analogs Bearing Pyrimidinone Moiety as Anticancer Agents.
Afzal O; Yusuf M; Ahsan MJ; Altamimi ASA; Bakht MA; Ali A; Salahuddin
Plants (Basel); 2022 Oct; 11(20):. PubMed ID: 36297760
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, DFT Analyses, Antiproliferative Activity, and Molecular Docking Studies of Curcumin Analogues.
Ahsan MJ; Choudhary K; Ali A; Ali A; Azam F; Almalki AH; Santali EY; Bakht MA; Tahir A; Salahuddin
Plants (Basel); 2022 Oct; 11(21):. PubMed ID: 36365289
[TBL] [Abstract][Full Text] [Related]
5. Molecular Engineering of Curcumin, an Active Constituent of
Ali A; Ali A; Tahir A; Bakht MA; Salahuddin ; Ahsan MJ
Plants (Basel); 2021 Jul; 10(8):. PubMed ID: 34451604
[TBL] [Abstract][Full Text] [Related]
6. Pro-Oncogenic c-Met/EGFR, Biomarker Signatures of the Tumor Microenvironment are Clinical and Therapy Response Prognosticators in Colorectal Cancer, and Therapeutic Targets of 3-Phenyl-2H-benzo[e][1,3]-Oxazine-2,4(3H)-Dione Derivatives.
Lawal B; Wang YC; Wu ATH; Huang HS
Front Pharmacol; 2021; 12():691234. PubMed ID: 34512327
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative Activity Predictor: A New Reliable In Silico Tool for Drug Response Prediction against NCI60 Panel.
Martorana A; La Monica G; Bono A; Mannino S; Buscemi S; Palumbo Piccionello A; Gentile C; Lauria A; Peri D
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430850
[TBL] [Abstract][Full Text] [Related]
8. Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3/CDK2/4/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines.
Lawal B; Liu YL; Mokgautsi N; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33477856
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
10. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Anticancer Effects of Brominated Plastoquinone Analogs with Promising Cytotoxic Activity in MCF-7 Breast Cancer Cells via Cell Cycle Arrest and Oxidative Stress Induction.
Jannuzzi AT; Yilmaz Goler AM; Bayrak N; Yıldız M; Yıldırım H; Karademir Yilmaz B; Shilkar D; Venkatesan RJ; Jayaprakash V; TuYuN AF
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890076
[TBL] [Abstract][Full Text] [Related]
12. Green Synthesis of Oxoquinoline-1(2H)-Carboxamide as Antiproliferative and Antioxidant Agents: An Experimental and In-Silico Approach to High Altitude Related Disorders.
Ali A; Ali A; Warsi MH; Rahman MA; Ahsan MJ; Azam F
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011539
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, ADME, and Anticancer Studies of Newer
Agarwal M; Afzal O; Salahuddin ; Altamimi ASA; Alamri MA; Alossaimi MA; Sharma V; Ahsan MJ
ACS Omega; 2023 Aug; 8(30):26837-26849. PubMed ID: 37593245
[TBL] [Abstract][Full Text] [Related]
14. Computational screening, ensemble docking and pharmacophore analysis of potential gefitinib analogues against epidermal growth factor receptor.
Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
J Recept Signal Transduct Res; 2018 Feb; 38(1):48-60. PubMed ID: 29369008
[TBL] [Abstract][Full Text] [Related]
15. Interactions between the epidermal growth factor receptor and type I protein kinase A: biological significance and therapeutic implications.
Ciardiello F; Tortora G
Clin Cancer Res; 1998 Apr; 4(4):821-8. PubMed ID: 9563874
[TBL] [Abstract][Full Text] [Related]
16. An Integrated Bioinformatics Study of a Novel Niclosamide Derivative, NSC765689, a Potential
Mokgautsi N; Wen YT; Lawal B; Khedkar H; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671112
[TBL] [Abstract][Full Text] [Related]
17. Anticancer activity of pyrimidodiazepines based on 2-chloro-4-anilinoquinazoline: synthesis, DNA binding and molecular docking.
Cuartas V; Aragón-Muriel A; Liscano Y; Polo-Cerón D; Crespo-Ortiz MDP; Quiroga J; Abonia R; Insuasty B
RSC Adv; 2021 Jul; 11(38):23310-23329. PubMed ID: 35479808
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Anticancer Activity of Curcumin Analogues Bearing a Heterocyclic Nucleus.
Ahsan MJ; Ahsan MJ
Asian Pac J Cancer Prev; 2016; 17(4):1739-44. PubMed ID: 27221847
[TBL] [Abstract][Full Text] [Related]
19. HLBT-100: a highly potent anti-cancer flavanone from
Lowe HIC; Toyang NJ; Watson CT; Ayeah KN; Bryant J
Cancer Cell Int; 2017; 17():38. PubMed ID: 28286420
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of thiazolidine-2,4-dione derivatives: anticancer, antimicrobial and DNA cleavage studies.
Laxmi SV; Anil P; Rajitha G; Rao AJ; Crooks PA; Rajitha B
J Chem Biol; 2016 Oct; 9(4):97-106. PubMed ID: 27698947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]